Giorgio Raimondi

The immune response is initiated by dendritic cells via interaction with microorganisms and interleukin-2 production.

Dendritic cells,tolerance and therapy of organ allograft rejection.

Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin.

Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells.

Induction of peripheral T cell tolerance by antigen-presenting B cells. I. Relevance of antigen presentation persistence.

Induction of peripheral T cell tolerance by antigen-presenting B cells. II. Chronic antigen presentation overrules antigen-presenting B cell activation.

Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses.

"Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.

Naturally occurring regulatory T cells: recent insights in health and disease.

Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.

Frontiers of immunological tolerance.

Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.

High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance.

Poor allostimulatory function of liver plasmacytoid DC is associated with pro-apoptotic activity, dependent on regulatory T cells.

Immunoregulatory functions of mTOR inhibition.

Tolerogenic dendritic cell-regulatory T-cell interaction and the promotion of transplant tolerance.

Rhesus monkey immature monocyte-derived dendritic cells generate alloantigen-specific regulatory T cells from circulating CD4+CD127-/lo T cells.

Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients.

Non-human primate regulatory T cells: current biology and implications for transplantation.

Controlled release formulations of IL-2, TGF-β1 and rapamycin for the induction of regulatory T cells.

Induced regulatory T cells: mechanisms of conversion and suppressive potential.

Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance.

IL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells.

Migratory, and not lymphoid-resident, dendritic cells maintain peripheral self-tolerance and prevent autoimmunity via induction of iTreg cells.

Bioinspired controlled release of CCL22 recruits regulatory T cells in vivo.

Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells.

All-trans retinoic acid and rapamycin synergize with transforming growth factor-β1 to induce regulatory T cells but confer different migratory capacities.

Persistent infection by HSV-1 is associated with changes in functional architecture of iPSC-derived neurons and brain activation patterns underlying working memory performance.

Donor age negatively affects the immunoregulatory properties of both adipose and bone marrow derived mesenchymal stem cells.

Taming inflammation by targeting cytokine signaling: new perspectives in the induction of transplantation tolerance.

The use of luminex assays to measure cytokines.

Abstract 11: the role of donor antigen persistance in maintaining immune tolerance to a vascularized composite allograft.

Abstract 102: inflammatory mediators modulate alloreactive T cell susceptibility to immune-regulation in reconstructive transplantation.

Exploring cell-based tolerance strategies for hand and face transplantation.

Exploring cell-based tolerance strategies for hand and face transplantation.